Equity Supply Stress Test: Can This Market Digest Billions in a Week?

The Supply Arrives All at Once

The first full week of August 2026 delivered what may be the most concentrated burst of equity supply in recent memory — and the market barely blinked.

Celestica (NYSE: CLS) closed a follow-on equity offering on August 6 that netted approximately $3.39 billion after fees, selling 9.68 million common shares at $310 apiece plus a fully exercised 1.45 million-share overallotment option. The total gross proceeds reached roughly $3.45 billion. The offering was priced at a 16.5% discount to Celestica’s Tuesday closing price, and the stock fell about 13% on the news. The company said the capital would fund AI infrastructure expansion across its data-center platform.^[1][2]

The same week, Prologis (NYSE: PLD) priced a $2.1 billion common stock offering — 15 million shares with a 2.25 million-share overallotment option that could push gross proceeds to $2.4 billion. The proceeds are earmarked to help finance Prologis’s accepted £14 billion ($18.8 billion) takeover of U.K. REIT SEGRO, one of the largest real-estate transactions of the year.^[3]

And on August 6, SpaceX (SPCX) passed a different kind of supply milestone: 911.5 million shares unlocked as the first post-IPO lockup expired, adding to the roughly 639 million shares sold in the June IPO. By December 8, cumulative lockup releases will push the float to 40% of the company’s total shares. The remaining 60% — including Elon Musk’s stake — stays locked until mid-2027.^[4]

A secondary offering of 20 million Primo Brands (NYSE: PRMB) shares by an affiliate of One Rock Capital Partners and a $300 million upsized stock sale by Twist Bioscience (Nasdaq: TWST) rounded out the week’s issuance menu.^[5]

The Market’s Reaction: Calm to the Point of Eerie

Here is what makes this supply wave remarkable: it landed against a backdrop of extraordinary complacency.

On Friday, August 8, the Cboe Volatility Index (VIX) closed at 15.15, its lowest level since January. The S&P 500 posted all-time highs above 7,700 for the first time, capping a weekly advance of 3.6%. More than four million S&P 500 index calls traded on Tuesday alone — a record — with zero-day-to-expiry calls accounting for 2.4 million of them. Total open interest in the S&P 500 ended the week at 27.4 million contracts, in the 93rd percentile over the past year.^[6][7]

In other words, the market wasn’t merely tolerating new equity supply; it was aggressively reaching for upside exposure at the same moment. Celestica’s stock took a 13% hit, but the broader tape never wobbled.

The supply-demand math explains why. Jay Ritter of the University of Florida, one of the leading academic authorities on IPO cycles, noted in a Goldman Sachs Research discussion that US publicly traded companies pay out roughly $600 billion annually in dividends and buy back about $1 trillion in stock — $1.6 trillion of cash that needs to be recycled. Even record IPO issuance is absorbing just a fraction of that flow.^[8]

The Counterweight: Buybacks Still Running

While new issuance surged, the buyback engine continued to churn:

^[9]

MetLife’s new $3 billion authorization is incremental to approximately $400 million remaining under its prior program. BASF’s August launch is part of a €4 billion multi-year buyback announced in September 2024, running through 2028. These programs represent the quiet structural demand that Ritter argues can absorb even large issuance waves — as long as big-tech repurchasers don’t pivot to becoming net issuers.

Owen Lamont of Acadian Asset Management flagged that pivot as the thing to watch: “If we come to a place where we see a huge wave of equity issuance and debt issuance, then I can’t make any statement about equity is overpriced or underpriced relative to debt. Then I would just say we have a pattern of external finance that companies are raising external finance.” So far, the Magnificent Seven are still repurchasing even as they issue debt. The moment they start issuing equity too is when the supply-demand balance shifts.^[8]

SpaceX: The Lockup Test

SpaceX offered the week’s most instructive market-structure experiment. Its June 12 IPO — the largest in US history by proceeds — made fewer than 5% of shares available for trading. That scarcity helped push the stock briefly above a $3 trillion valuation, surpassing Microsoft and Amazon. Since then, reality has set in: shares have lost more than a quarter of their value, trading below the $135 IPO price for three straight weeks before the lockup expired.^[4]

The lockup expiry on August 6 was widely feared. Bloomberg estimated that $101 billion in shares would unlock. Yet SpaceX stock rose 1.4% to $109.86 on heavy volume — over $23 billion worth of shares traded in the session — as buyers stepped in where sellers were expected.^[4][10]

That said, the structural supply is only beginning. Through December 8, successive lockup releases will bring the tradeable float to 40% of the company. The remaining 60% stays locked until mid-2027. Each tranche is a potential supply event, and SpaceX’s first earnings report as a public company — which triggered a 14% selloff on August 5 — showed the fundamental case is still contested. Revenue jumped, but operating losses and AI-infrastructure spending plans rattled investors.^[4]

The Bigger Picture: Is This a Wave or a Ripple?

The 2026 IPO market has already raised $251 billion across 86 US IPOs, surpassing all of 2025.^[11] EY’s Q2 2026 Global IPO Trends report described the first-half activity as setting the stage for what “could be a historic 2H 2026,” with execution windows shaped by mega-IPOs and geopolitics.^[11] General Atlantic’s capital markets team observed that the comeback is beginning to broaden beyond AI mega-deals into mid-cap issuers and underrepresented sectors.^[11]

But both Ritter and Lamont, speaking to Goldman Sachs, cautioned against calling this an IPO wave — at least not yet. Ritter noted that the number of operating-company IPOs remains modest by historical standards, averaging just over 100 per year since the internet bubble, compared with over 300 per year in the 1980s and 1990s. The record proceeds are driven by a handful of mega-deals, not a broad flood of new listings. Lamont’s framework: “It takes more than one IPO to constitute a wave.”^[8]

The first-day pop tells a similar story. In true speculative bubbles — 1999, 2021 — IPOs routinely surged 50% to 100% on debut. We have not seen pops of that magnitude in 2026, which Lamont cites as evidence that “we are not in a speculative euphoria.”^[8]

Still, LPL Research flagged that the 2026 IPO calendar is “unusually consequential,” with large listings capable of influencing indexes, passive flows, and the AI narrative — and that market structure may amplify volatility through low floats, passive ownership, and faster index inclusion.^[11]

What to Watch Next

• SpaceX lockup tranches through December 8. Each release adds supply. The August 6 unlock was absorbed, but subsequent tranches — and any insider selling disclosure — will test whether the buyer base is durable or a one-time overshoot.
• Celestica’s use of proceeds. The company said the $3.39 billion will fund AI infrastructure capex. If other large-cap names follow Celestica’s lead and issue equity specifically for AI buildout — rather than relying on debt — that shifts the supply-demand equation Lamont is watching.
• Prologis-SEGRO close. The $18.8 billion REIT takeover requires regulatory clearance and shareholder votes. If the deal closes, Prologis’s equity issuance sets a pricing benchmark for future large-cap REIT follow-ons.
• Buyback vs. issuance balance. The $1.6 trillion annual payout-recycling mechanism Ritter describes has comfortably absorbed 2026’s supply. The leading indicator to monitor is whether the Magnificent Seven shift from net repurchasers to net issuers — Lamont’s “fourth horseman” signal.
• VIX behavior. A VIX at 15.15 alongside record options call buying is the kind of configuration that Allianz Global Investors warned can “snap violently without warning.”^[6] If a supply event coincides with a volatility spike, the absorption capacity that looks effortless at VIX 15 may look very different at VIX 25.

This article is for research and education purposes only and does not constitute investment advice.